| Ytd | -50.49% | |
| 1y | -91.43% |
| Open | 0.13 | Prev Close | 0.14 | Low | 0.13 | High | 0.14 | Mkt Cap | 1.46M |
| Vol | 334.02K | Avg Vol | 11.64M | EPS | -3.27 | P/E | -0.04 | Forward P/E | -0.78 |
| Beta | -1.21 | Short Ratio | 1.34 | Inst. Own | 1.82% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.19 | 200-d Avg | 0.29 | 1yr Est | 3.50 |
AZTR News
ATR-COSF uses a supernatant based formulation containing an active recombinant human domain of the p
ATR-COSF uses a supernatant based formulation containing an active recombinant human domain of the p
ATR-COSF uses a supernatant based formulation containing an active recombinant human domain of the p
Gainers Adicet Bio (NASDAQ:ACET) stock moved upwards by 22.9% to $10.14 during Thursday's pre-m
Gainers HeartSciences (NASDAQ:HSCS) stock rose 82.2% to $3.23 during Tuesday's pre-market sessi
Gainers Tenon Medical (NASDAQ:TNON) shares increased by 115.8% to $0.76 during Monday's pre-mar
SAGTEC GLOBAL (NASDAQ: SAGT) gained 75.6% in pre-market trading after projecting 35% revenue growth
Planet Labs (PL) stock rose in pre-market trading after better-than-expected Q4 sales and strong FY2
Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCo